Here, we show that the activation of cellular cholesterol metabolism is important for inflammatory activation of monocytes/macrophages dependent on myeloid differentiation primary response 88 (Myd88) and is an attractive immunometabolic target for novel therapeutic strategies against atherosclerosis. Here, MYD88 is linked to atherosclerosis.